Evidence map›Paper›PMID 29758038›Full record

Trial reportPloS one2018

Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.

Tobias Peikert, Fenghai Duan, Srinivasan Rajagopalan, Ronald A Karwoski, Ryan Clay, Richard A Robb, Ziling Qin, JoRean Sicks, Brian J Bartholmai, Fabien Maldonado

Erratum issuedAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Validation of the BRODERS classifier (BenignThe European respiratory journal · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Tobias PeikertDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States of America.
Fenghai DuanDepartment of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island, United States of America.
Srinivasan RajagopalanDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States of America.
Ronald A KarwoskiDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States of America.
Ryan ClayDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States of America.
Richard A RobbDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States of America.
Ziling QinDepartment of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island, United States of America.
JoRean SicksCenter for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island, United States of America.
Brian J BartholmaiDepartment of Radiology, Mayo Clinic, Rochester, MN, United States of America.ORCID 0000-0001-7834-6579
Fabien MaldonadoDivision of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TN, United States of America.ORCID 0000-0002-6504-2063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOptimization of the clinical management of screen-detected lung nodules is needed to avoid unnecessary diagnostic interventions. Herein we demonstrate the potential value of a novel radiomics-based approach for the classification of screen-detected indeterminate nodules. MATERIAL AND

methodsIndependent quantitative variables assessing various radiologic nodule features such as sphericity, flatness, elongation, spiculation, lobulation and curvature were developed from the NLST dataset using 726 indeterminate nodules (all ≥ 7 mm, benign, n = 318 and malignant, n = 408). Multivariate analysis was performed using least absolute shrinkage and selection operator (LASSO) method for variable selection and regularization in order to enhance the prediction accuracy and interpretability of the multivariate model. The bootstrapping method was then applied for the internal validation and the optimism-corrected AUC was reported for the final model.

resultsEight of the originally considered 57 quantitative radiologic features were selected by LASSO multivariate modeling. These 8 features include variables capturing Location: vertical location (Offset carina centroid z), Size: volume estimate (Minimum enclosing brick), Shape: flatness, Density: texture analysis (Score Indicative of Lesion/Lung Aggression/Abnormality (SILA) texture), and surface characteristics: surface complexity (Maximum shape index and Average shape index), and estimates of surface curvature (Average positive mean curvature and Minimum mean curvature), all with P<0.01. The optimism-corrected AUC for these 8 features is 0.939.

conclusionsOur novel radiomic LDCT-based approach for indeterminate screen-detected nodule characterization appears extremely promising however independent external validation is needed.

Indexed as

Mass ScreeningTomography, X-Ray ComputedAgedFemaleHumansLungMaleMiddle AgedMultiple Pulmonary Nodules

Identifiers

PMID29758038
PMCPMC5951567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.